by Richard Daverman, PhD
August 21, 2012 -- Joincare Pharmaceutical Group announced that its Board has approved the investment of 1 billion RMB ($157 million) to increase the company’s production of carbapenem antibiotics. The project will be located in Fuping New Area, Shenzhen. Joincare is based in Shenzhen and sells its pharmaceutical products mainly in the southeast coastal provinces of China. More details....
Stock Symbol: (SHA: 600380)
